Literature DB >> 2561579

Seroepidemiological study of Epstein-Barr virus infection in children in Taipei.

W S Tsai, M H Chang, J Y Chen, C Y Lee, Y G Liu.   

Abstract

SerumIgG antibody titer against viral capsid antigen(VCA) of Epstein-Barr virus (EBV) was measured by indirect immunofluorescence antibody method in 1350 children under 15 years of age, 723 males and 627 females, who were living in the Taipei area. Sera were collected from June through October 1984. Under the age of 6 months, the prevalence rate of positive serum VCA antibody was 38.4%. It decreased to 6.4% between 6 and 12 months of age, but rose to 65.8% during the second year of life. The rate continued to increase from 1 to 4 years of age, with a steep rise of geometric mean titer in the same period. The prevalence rate stayed at more than 90% after 4 years of age. From our data, it is obvious that most children in the Taipei area had been infected by EBV in early childhood, especially from 1 to 4 years of age.

Entities:  

Mesh:

Year:  1989        PMID: 2561579

Source DB:  PubMed          Journal:  Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi        ISSN: 0001-6578


  3 in total

1.  Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice.

Authors:  M Chang; M-R Pan; D-Y Chen; J-L Lan
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

2.  The correlation between EBV viral load in the palatine tonsils of patients with recurrent tonsillitis and concurrent serum titers of VCA–IgG.

Authors:  Bora Dogan; Seyyal Rota; Levent Gurbuzler; Gulendam Bozdayi; Mustafa Nuri Ceyhan; Erdogan Inal
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01       Impact factor: 2.503

3.  A large-scale seroprevalence of Epstein-Barr virus in Taiwan.

Authors:  Chao-Yu Chen; Kuan-Ying A Huang; Jen-Hsiang Shen; Kuo-Chien Tsao; Yhu-Chering Huang
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.